{"transactions":[{"id":4637845,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28608,"kind":"person","name":"Jerman Michael Allen","position":1,"cik":"0001979732","reported_name":"Jerman Michael Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-08T20:30:09.000Z","date":"2026-10-06","kind":"grant","planned":false,"acquired":true,"shares":20990,"price":0.7444,"value":15624.956,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of board fees."}],"balance_after":44749,"source":{"system":"sec-edgar","filing":"0001193125-26-417974","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1979732/000119312526417974/ownership.xml","form_type":"4"}},{"id":703101,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28608,"kind":"person","name":"Jerman Michael Allen","position":1,"cik":"0001979732","reported_name":"Jerman Michael Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-27T20:15:29.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":8138,"price":1.92,"value":15624.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of board fees."}],"balance_after":23759,"source":{"system":"sec-edgar","filing":"0001193125-26-318114","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312526318114/ownership.xml","form_type":"4"}},{"id":728062,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":28608,"kind":"person","name":"Jerman Michael Allen","position":1,"cik":"0001979732","reported_name":"Jerman Michael Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T16:34:53.000Z","date":"2026-05-04","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2025 Equity Incentive Plan."}],"balance_after":180411,"source":{"system":"sec-edgar","filing":"0001493152-26-029898","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000149315226029898/ownership.xml","form_type":"4"}},{"id":795988,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28608,"kind":"person","name":"Jerman Michael Allen","position":1,"cik":"0001979732","reported_name":"Jerman Michael Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-01T20:15:27.000Z","date":"2026-04-29","kind":"grant","planned":false,"acquired":true,"shares":6032,"price":2.59,"value":15622.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of board fees."}],"balance_after":15621,"source":{"system":"sec-edgar","filing":"0001193125-26-201474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312526201474/ownership.xml","form_type":"4"}},{"id":938660,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28608,"kind":"person","name":"Jerman Michael Allen","position":1,"cik":"0001979732","reported_name":"Jerman Michael Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-15T21:15:04.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":5406,"price":2.89,"value":15623.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued in lieu of board fees."}],"balance_after":9589,"source":{"system":"sec-edgar","filing":"0001193125-26-014117","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312526014117/ownership.xml","form_type":"4"}},{"id":987516,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28608,"kind":"person","name":"Jerman Michael Allen","position":1,"cik":"0001979732","reported_name":"Jerman Michael Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-27T02:26:01.000Z","date":"2025-11-21","kind":"grant","planned":false,"acquired":true,"shares":4183,"price":3.16,"value":13218.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock issued in lieu of board fees."}],"balance_after":4183,"source":{"system":"sec-edgar","filing":"0001193125-25-301025","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000119312525301025/ownership.xml","form_type":"4"}},{"id":1085821,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28608,"kind":"person","name":"Jerman Michael Allen","position":1,"cik":"0001979732","reported_name":"Jerman Michael Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-07-17T21:35:05.000Z","date":"2025-07-15","kind":"grant","planned":false,"acquired":true,"shares":3200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-twelfth of the Option vests each month on the monthly anniversary of July 15, 2025, with any amount that remains unvested on the date immediately preceding the Company's 2026 annual general meeting of stockholders vesting thereon. Vesting shall accelerate in full upon Optionholder's death or Disability or a Change of Control."}],"balance_after":3200,"derivative":{"exercise_price":3.4,"expiration_date":"2035-07-14","underlying":"Common Stock","underlying_shares":3200},"source":{"system":"sec-edgar","filing":"0000950170-25-096674","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025096674/ownership.xml","form_type":"4"}},{"id":1085820,"issuer":{"id":8339,"kind":"organization","name":"Alaunos Therapeutics, Inc.","symbol":"TCRT"},"owners":[{"id":28608,"kind":"person","name":"Jerman Michael Allen","position":1,"cik":"0001979732","reported_name":"Jerman Michael Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-07-17T21:35:05.000Z","date":"2025-07-15","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-thirty sixth of the shares underlying the option vest in equal monthly installments measured from December 29, 2023, with the first vesting occurring on January 29, 2024, subject to the Reporting Person's continued service through each such date."}],"balance_after":10000,"derivative":{"exercise_price":3.4,"expiration_date":"2035-07-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000950170-25-096674","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025096674/ownership.xml","form_type":"4"}},{"id":1176936,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":28608,"kind":"person","name":"Jerman Michael Allen","position":1,"cik":"0001979732","reported_name":"Jerman Michael Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-07T21:21:06.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2014 Equity Incentive Plan."}],"balance_after":80411,"source":{"system":"sec-edgar","filing":"0001641172-25-003023","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000164117225003023/ownership.xml","form_type":"4"}},{"id":1419603,"issuer":{"id":6962,"kind":"organization","name":"Telomir Pharmaceuticals, Inc."},"owners":[{"id":28608,"kind":"person","name":"Jerman Michael Allen","position":1,"cik":"0001979732","reported_name":"Jerman Michael Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Incentive Stock Options (right to buy)","published_at":"2024-08-29T20:05:20.000Z","date":"2024-08-27","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on August 26, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the \"Plan\"). Fifty percent of the stock options vested immediately upon issuance and the remaining fifty percent of the stock options are to vest on February 26, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The stock options were issued to the Reporting Person on August 26, 2024, pursuant to a grant under the Issuer's 2023 Omnibus Incentive Plan, as amended and restated (the \"Plan\"). Fifty percent of the stock options vested immediately upon issuance and the remaining fifty percent of the stock options are to vest on February 26, 2025."}],"balance_after":25000,"derivative":{"exercise_price":5.02,"expiration_date":"2034-08-27","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-24-034373","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971532/000149315224034373/ownership.xml","form_type":"4"}},{"id":1514706,"issuer":{"id":7783,"kind":"organization","name":"Inhibitor Therapeutics, Inc."},"owners":[{"id":28608,"kind":"person","name":"Jerman Michael Allen","position":1,"cik":"0001979732","reported_name":"Jerman Michael Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-16T17:34:29.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted common stock issued to the Reporting Person as compensation pursuant to the Issuer's 2014 Equity Incentive Plan."}],"balance_after":80411,"source":{"system":"sec-edgar","filing":"0001493152-24-020170","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1042418/000149315224020170/ownership.xml","form_type":"4"}},{"id":1559124,"issuer":{"id":7362,"kind":"organization","name":"MIRA PHARMACEUTICALS, INC."},"owners":[{"id":28608,"kind":"person","name":"Jerman Michael Allen","position":1,"cik":"0001979732","reported_name":"Jerman Michael Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Nonqualified Stock Option (right to buy)","published_at":"2024-03-27T21:53:39.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted under the Issuer's 2022 Omnibus Incentive Plan whereby 50% of such options, or 25,000 options, vested immediately on the grant date of March 25, 2024, and the remaining 50% vest on the first anniversary of the grant date, March 25, 2025."}],"balance_after":25000,"derivative":{"exercise_price":1.16,"expiration_date":"2034-03-25","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-24-011571","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1904286/000149315224011571/ownership.xml","form_type":"4"}}]}